Omnicell

Omnicell FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Omnicell (OMCL) as of Oct 29, 2026 is 4,234.16 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 1,207.08 % — a change of 250.78% (higher).

FCF Conversion

4,234.16 %

YoY

250.78%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Omnicell is 2025 4,234.16 % . FCF Conversion Rate (FCF/EBITDA) of Omnicell was 2024 1,207.08 % . It decreases by 250.78% higher compared to the previous year.

The Omnicell FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
131.44 USD
Jan 1, 2019
135.88 USD
Jan 1, 2020
406.92 USD
Jan 1, 2021
260.56 USD
Jan 1, 2022
301.72 USD
Jan 1, 2023
-685.39 USD
Jan 1, 2024
1,207.08 USD
Jan 1, 2025
4,234.16 USD
The Omnicell FCF Conversion history
YEARFCF ConversionYoY
4,234.16 %+250.78%
1,207.08 %-276.12%
-685.39 %-327.16%
301.72 %+15.80%
260.56 %-35.97%
406.92 %+199.48%
135.88 %+3.37%
131.44 %-574.57%
-27.70 %-100.89%
3,113.10 %+6,903.51%
44.45 %-68.13%
139.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Omnicell Stock analysis

What does Omnicell do? Omnicell Inc. is a leading company in the healthcare industry, specializing in the development and provision of innovative automation solutions for medication and other critical medical supplies. The company was founded in 1992 and is headquartered in Mountain View, California, USA. Over the years, Omnicell has grown into a global company with offices in North America, Europe, Asia, and the Middle East. Omnicell's business model is to offer products, services, and solutions that allow healthcare facilities to optimize their processes, increase patient safety, and save costs. Omnicell provides innovative automation solutions, particularly for medication management, sterilization, and inventory control. Omnicell offers various solutions to improve medication management in clinics. This includes, for example, the medication cabinet, which has an integrated computer system that allows for the quick and easy identification and retrieval of needed medications. Omnicell also offers solutions for sterilizing medical materials to ensure patient safety, as well as automated storage systems for managing medical supplies. In recent years, the company has focused heavily on developing solutions to improve patient safety. One example is Omnicell's Medical Intelligence platform, which automatically detects and notifies of medication errors and other issues, thereby enhancing patient safety. Omnicell's products are used by a wide range of healthcare facilities, from small doctor's offices to large hospitals and health centers. The company has also established relationships with major retailers to sell its products, such as CVS and Walgreens in the USA. In addition to its core products and services, Omnicell also provides training and support to customers to ensure they can make optimal use of their products. The company also has its own research and development department to continuously develop new and innovative products and solutions. Overall, Omnicell aims to transform the healthcare industry through innovative automation solutions. Through its products, services, and solutions, the company has already helped many healthcare facilities improve their processes and increase patient safety. Omnicell will continue to invest in the development of new products and technologies to optimize the healthcare industry in the long term. Omnicell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omnicell stock

FCF Conversion Rate (FCF/EBITDA) of Omnicell is 4,234.16 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Omnicell changed from 1,207.08 % to 4,234.16 %, representing a 250.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Omnicell since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Omnicell with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Omnicell

All Key Metrics — Omnicell